Correspondence 0001193125-23-209690 from Burning Rock Biotech Ltd (BNR)
Burning Rock Biotech Ltd
Date: Aug. 11, 2023 · CIK: 0001792267 · Accession: 0001193125-23-209690
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 001-39316
Letter
VIA EDGAR Division of Corporation Finance Re: Burning Rock Biotech Limited (the “Company”) Form 20-F for the Year Ended December 31, 2022 (“FY 2022 20-F”) Filed April 20, 2023 File No. 001-39316
Dear Mr. Howes and Ms. Gowetski:
The Company confirms receipt of the comments on its FY 2022 20-F from the Securities and Exchange Commission dated August 3, 2023 (the “Comment Letter”). The Company respectfully requests an extension to respond to the Comment Letter and will provide its responses via EDGAR as soon as possible, and in any event no later than August 31, 2023.
If you have any questions regarding the FY 2022 20-F, please contact Leo Li, the chief financial officer of Burning Rock Biotech Limited, by telephone at +86 020-3403 7871 or via e-mail at leo.li@brbiotech.com.
Very truly yours,
By:
Show Raw Text
CORRESP 1 filename1.htm CORRESP Burning Rock Biotech Limited No. 5, Xingdao Ring Road North International Bio Island, Guangzhou, 510005 People’s Republic of China August 11, 2023 VIA EDGAR Tyler Howes Jennifer Gowetski Division of Corporation Finance Disclosure Review Program U.S. Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 Re: Burning Rock Biotech Limited (the “Company”) Form 20-F for the Year Ended December 31, 2022 (“FY 2022 20-F”) Filed April 20, 2023 File No. 001-39316 Dear Mr. Howes and Ms. Gowetski: The Company confirms receipt of the comments on its FY 2022 20-F from the Securities and Exchange Commission dated August 3, 2023 (the “Comment Letter”). The Company respectfully requests an extension to respond to the Comment Letter and will provide its responses via EDGAR as soon as possible, and in any event no later than August 31, 2023. If you have any questions regarding the FY 2022 20-F, please contact Leo Li, the chief financial officer of Burning Rock Biotech Limited, by telephone at +86 020-3403 7871 or via e-mail at leo.li@brbiotech.com. Very truly yours, By: /s/ Leo Li Name: Leo Li Title: Chief Financial Officer cc: Ms. Shuang Zhao, Partner, Cleary Gottlieb Steen & Hamilton LLP